PYVAX | RMEBX | PYVAX / RMEBX | |
Total Expense Ratio | 1.01 | 1.07 | 94% |
Annual Report Gross Expense Ratio | 1.01 | 1.07 | 94% |
Fund Existence | 14 years | 11 years | - |
Gain YTD | 0.606 | 5.923 | 10% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 5000 | 250 | 2,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 1.01B | 106B | 1% |
Annual Yield % from dividends | 1.00 | 1.16 | 87% |
Returns for 1 year | -8.15 | 8.54 | -95% |
Returns for 3 years | 3.89 | 27.89 | 14% |
Returns for 5 years | 11.88 | 58.69 | 20% |
Returns for 10 years | 40.11 | 68.22 | 59% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
SARK | 40.56 | -0.04 | -0.10% |
Tradr 1X Short Innovation Daily ETF | |||
CGSD | 25.84 | -0.03 | -0.12% |
Capital Group Short Duration Income ETF | |||
FEMB | 28.36 | -0.11 | -0.39% |
First Trust Emerging Mkts Lcl Ccy Bd ETF | |||
JEPQ | 52.59 | -0.45 | -0.85% |
JPMorgan Nasdaq Equity Premium Inc ETF | |||
DWLD | 40.21 | -0.66 | -1.61% |
Davis Select Worldwide ETF |